Warfarin: A Higher “High-Risk” Medication?

References 

1. Jacobs LG. Warfarin pharmacology, clinical management of evaluation of hemorrhage risk for the elderly. Clin Geriatr Med. 2006;22:17–32
   • Abstract
   • Full Text
   • Full-Text PDF (159 KB)
   • CrossRef
2. Ocava LC, Singh M, Malhotra S, et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Clin Geriatr Med. 2006;22:135–154
   • Abstract
   • Full Text
   • Full-Text PDF (198 KB)
   • CrossRef
3. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:204–233
4. Goldstein LB, Hankey GJ. Advances in primary stroke prevention. Stroke 2006. 2006;37:317–319available at http://strokeaha.org.
5. Garcia DA, Hylek EM. Antithrombotic therapy in atrial fibrillation. Clin Geriatr Med. 2006;22:155–166
   • Abstract
   • Full Text
   • Full-Text PDF (152 KB)
   • CrossRef
6. Coumadin^® Tablets (warfarin sodium, USP), Product information. Bristol-Myers Squibb, Princeton, NJ 08543 April 2006, Approved 2, revised October 2006.
7. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med. 1998;105:91–99
   • Abstract
   • Full Text
   • Full-Text PDF (156 KB)
   • CrossRef
8. Zhang K, Young C, Berger J. Administrative claims analysis of the relationship between warfarin use and risk of hemorrhage including drug-drug and drug-disease interactions. J Manag Care Pharm. 2006;12:640–648
   • MEDLINE
9. Multidisciplinary Medication Management Project, American Medical Directors Association and the American Society of Consultant Pharmacists. Available at http://scoup.net/m3project/about/index.htm. Cited November 19, 2006.
10. Coumadin Tablets^® (warfarin sodium, USP). News. U.S. Food and Drug Administration Center for Drug Evaluation and Research, October 10, 2006. Available at www.fda.gov/medwatch/safety/2006/safety06.htm#Coumadin. Cited November 19, 2006.
11. Unnecessary Medications. Centers for Medicare and Medicaid, Department of Health and Human Services, 42CFR§483.25(I)(1),(2) F329. Available at http://ascp.com/resources/nhsurvey/upload/S&C-06-29.04-F329%20REV.pdf. Cited November 19, 2006.
12. Drug Regimen Review. Centers for Medicare & Medicaid, Department of Health and Human Services, 42 CFR483.60(c)(1)(2) Medication Regimen Review. Available at http://ascp.com/resources/nhsurvey/upload/S&C-06-29.06-F428.pdf. Cited November 19, 2006.